CANCER
1PMPyU0
1PMPyU0
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Bloodwise 50<br />
Group statement of financial activities for the year ended 31 March 2015<br />
Group statement of financial activities for the year<br />
ended 31 March 2015<br />
INCORPORATING THE INCOME AND EXPENDITURE ACCOUNT<br />
Notes<br />
Restricted<br />
Funds<br />
2015 2015 2015 2014<br />
Unrestricted<br />
Funds<br />
Total<br />
Total<br />
£'000 £'000 £'000 £'000<br />
INCOMING RESOURCES<br />
Incoming resources from generated funds<br />
Voluntary income 723 11,410 12,133 12,731<br />
Legacies 339 5,898 6,237 6,809<br />
1,062 17,308 18,370 19,540<br />
Activities for generating funds<br />
Trading income (LLRT) 7 - 796 796 581<br />
Investment income 1 - 1,422 1,422 1,535<br />
TOTAL INCOMING RESOURCES 1,062 19,526 20,588 21,656<br />
RESOURCES EXPENDED<br />
Cost of generating funds<br />
Fundraising and marketing - 5,728 5,728 5,380<br />
Trading expenditure (LLRT) 7 - 355 355 257<br />
Investment management fees - 199 199 235<br />
- 6,282 6,282 5,872<br />
Charitable activities 2<br />
Research 560 32,606 33,166 24,168<br />
Deferred funding - (7,535) (7,535) (3,862)<br />
Unspent funds at completion of grant - (2,057) (2,057) (679)<br />
Patient benefit activities - 1,503 1,503 815<br />
560 24,517 25,077 20,442<br />
Governance costs - 202 202 251<br />
TOTAL RESOURCES EXPENDED 560 31,001 31,561 26,565<br />
NET INCOMING / (OUTGOING) RESOURCES,<br />
BEING NET EXPENDITURE FOR THE YEAR,<br />
BEFORE TRANSFERS 3 502 (11,475) (10,973) (4,909)<br />
Bloodwise trading as Leukaemia & Lymphoma Research Company limited by guarantee 738089<br />
Registered charity 216032 (England & Wales) SC037529 (Scotland)
Change language